Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide in Stored Blood Transfusion
NCT01529502Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2012
- Primary completion
- Dec 2013
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in pulmonary hypertension (PH), endothelial dysfunction, sponsored by Massachusetts General Hospital. Started Mar 2012; status: completed.
02
Drugs
nitric oxide
03
Conditions
pulmonary hypertension (PH)endothelial dysfunction
Beyond the preview
Go deeper on NCT01529502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01529502.